Let’s rise to the challenges ahead
It’s been a while since we got together for ‘live’ debate, so what a treat to be given DDN sessions at HRI’s online Constellations event. We chose to focus on naloxone action, peer-led initiatives on hepatitis C, and two issues that have fired up our pages for many years – ensuring people are on the dose that suits them, and the all-important dialogue that moves way beyond the ‘harm reduction v recovery’ days and focuses on our collective assets and interests.
Our reports on pages 10, 12, 16 and 21 give a flavour of the will – and urgent need – to unite on these vital issues. The timing and the need to challenge spending cuts could not be more important, so please send us your thoughts and let’s keep up momentum.
Getting – and giving – the right dose means staying informed enough to make these decisions, so we’re excited to offer the first in an authoritative and independent three-parter on buprenorphine (page 6). It’s part of our role to present the facts while giving you the forum to debate, question and offer vital lived experience to complete the picture. And as we take stock of the year that was (p23), let’s be thankful for the will to communicate, which helps our sector rise to the challenges ahead. Have a happy and safe festive season and here’s to strong bonds between all of us in 2022.
Claire Brown, editor
Please send your letters and comment to firstname.lastname@example.org